Novartis Q3 Results Climb, Despite Generic Erosion In US; Confirms FY25 Outlook
28/10 07:27
(RTTNews) - Swiss drug major Novartis AG (NVS) reported Tuesday higher net income in its third quarter, benefited by sales growth above market estimates. Looking ahead for fiscal 2025, the company continues to expect core operating income to grow in low-teens and sales to grow in...